Salesforce agreed to acquire customer engagement platform Braze for $47.50 per share in cash on October 20, 2026. The transaction values the target company at an enterprise value of approximately $5.66 billion, as confirmed in the acquirer's...
KKR & Co., Energy Capital Partners and Blackstone Inc. are competing against a rival group formed by Brookfield Asset Management and IFM Investors to acquire GFL Environmental Inc. for between $50 and $55 per share, according to Bloomberg on...
EQT Infrastructure entered a binding Scheme Implementation Deed on 19 October 2026 to acquire Cleanaway Waste Management Limited for A$3.095 per share in cash. The transaction values the Australian waste operator at an enterprise value of...
Carlyle Group Inc. agreed on October 14, 2026, to purchase a consumer loan portfolio with a gross value of 7.7 billion dollars from Truist Financial Corporation. The transaction was announced on October 16, 2026. Truist expects to receive...
SoftBank Group Corp. is exploring the acquisition of Allied Universal in a transaction that values the privately held security services company at up to $30 billion, according to Bloomberg on October 16, 2026. The potential purchase targets an...
Galderma Group AG agreed to acquire ZO Skin Health Inc. from Blackstone Tactical Opportunities and the Obagi family for an enterprise value of $1.5 billion. The all-cash transaction buys a California-based clinical skincare business that sells...
BlackRock entered an agreement on October 13, 2026, to acquire the majority equity stake in a primary care joint venture from Welsh, Carson, Anderson & Stowe for $2.8 billion. The transaction establishes a new partnership structure for Humana,...
STERIS Corporation, a wholly owned operating subsidiary of STERIS plc, agreed to buy Xodus Medical, Inc. for $2.1 billion in cash on October 12, 2026, according to a corporate press release published on the same day. The buyer plans to extract...
Viatris Inc. agreed to purchase Pacira BioSciences Inc. for $36.50 per share in cash on October 8, 2026, establishing an equity valuation of approximately $1.65 billion. The transaction establishes a 44.8 percent premium over the closing price of...
Shionogi & Co., Ltd. agreed to acquire IntraBio Inc. for $2.0 billion in an all-cash transaction announced on October 5, 2026. The Japanese pharmaceutical company will purchase 100 percent of the outstanding shares of the Austin, Texas-based...